Home / Education / Education Courses / 3rd International Psychopharmacology: Depression & Schizophrenia: International Perspectives on Global Disorders

3rd International Psychopharmacology: Depression & Schizophrenia: International Perspectives on Global Disorders

Event Date(s): May 14, 2021 - 08:30am to May 16, 2021 - 12:20pm

     This psychiatry conference examines the latest research and treatment advances across dozens of mental health conditions. It offers in-depth information that is important for all mental health and primary care settings. Topics for this conference go in depth into the examination depression and schizophrenia. In every session, our faculty share any data from new clinical trials. They match it up against prior data and discuss what the changes mean. They also examine standards of care and share innovative ways to make care better. The agenda touches on many complex topics in mental health. Managing side effects, drug interactions, combining pharmacologic and psychosocial treatments, and much more.    

Available Credits: 11.25 AMA PRA Category 1 Credit™ 11.25 Nursing Contact Hours 11.25 Social Workers 11.25 Participation 11.25 Psychologists CE Credit Register For This Course

Course Details

 

Now Virtual!  


 

INTERNATIONAL PERSPECTIVES ON GLOBAL DISORDERS

Engage the experts. Get your questions answered.

This psychiatry conference examines the latest research and treatment advances across two classes of mental health conditions significant around the globe. It offers in-depth information that is important for all mental health and primary care settings. Topics for this conference go in depth into the examination depression and schizophrenia.

Our expert speakers will address conditions from European and North American perspectives. In every session, our faculty share any data from new clinical trials. They match it up against prior data and discuss what the changes mean. They also examine standards of care and share innovative ways to make care better. The agenda touches on many complex topics in mental health. Managing side effects, drug interactions, combining pharmacologic and psychosocial treatments, and much more.

Most important of all, our faculty focus on how to translate all these insights into your daily practice. This empowers you to optimize your care for patients with psychiatric conditions. That makes our event ideal for professionals in psychiatry, primary care, psychology, and nursing.

Take advantage of this chance to ask our experts questions during the virtual panel!

Conference will be held in Eastern Standard Time (EST).

PRICE

MDs/Doctoral-Level Professionals
Super Early Bird Registration (on or before March 1, 2021): $495.00
Early Bird Registration (on or before April 1, 2021): $525.00
Regular Registration (after April 1, 2021): $595.00

Other Professionals or Trainees
Super Early Bird Registration (on or before March 1, 2021): $395.00
Early Bird Registration (on or before April 1, 2021): $425.00 
Regular Registration (after April 1, 2021): $495.00

CANCELLATION POLICY

A refund minus a $100.00 administrative fee will be issued for refund requests received by April 23, 2021. No refunds will be issued for refund request made after April 23, 2021. Payments made may not be applied to future conferences or other educational activities. There are no exceptions to these policies.

E-SYLLABUS

We provide all attendees with completely free access to all slide presentations in digital PDF format prior to the conference. This is an environmentally friendly alternative and helps keep costs lower for all attendees. The e-syllabus will be available for 30 days after the conference. 

Course Summary

Available Credits:11.25 AMA PRA Category 1 Credit™ 11.25 Nursing Contact Hours 11.25 Social Workers 11.25 Participation 11.25 Psychologists CE Credit
Course Format:Conference / meeting
Target Audience:

This program is intended for:

  • Psychiatrists
  • Psychologists
  • General and Family Practice Physicians
  • Psychiatric Nurses
  • Physician Assistants 
  • Nurse Practitioners 
  • Social Workers
Event Starts: May 14, 2021 - 08:30am
Event Ends: May 16, 2021 - 12:20pm
Cost: $595.00

Learning Objectives

  1.  Identify rational, evidence-based pharmacologic and non-pharmacologic therapies for patients with unipolar, bipolar, and treatment-resistant depression.
  2.  Identify rational, evidence-based pharmacologic and non-pharmacologic therapies for patients with unipolar, bipolar, and treatment-resistant schizophrenia.
  3.  Assess obstacles to maintenance of long-term recovery and the liability issues associated with psychopharmacology.
  4.  Discuss diagnostic and evidenced-based treatment strategies for pediatric onset mood disorders.
  5. Compare the newest medications in the pipeline for depression and schizophrenia to those which are currently being used.
  6. Discuss the usefulness of well being therapy in depression.
  7. Discuss the use of brain stimulation in treatment refractory depression
  8.  Analyze the evolution of antipsychotic therapy with an emphasis on long acting injectable medication.
  9. Compare the neurobiology and evidence-based treatment approaches to schizophrenia and mood disorders.